Report claims Nvidia will not be releasing any new RTX gaming GPUs in 2026, RTX 60 series likely debuting in 2028

Nvidia has reportedly paused any new consumer RTX GPU launches in 2026 and pushed the next-generation RTX 60 series beyond 2027, with mass production now likely in 2028, after completing an RTX 50 Super design that will not be prioritized. The delays are attributed to constrained memory (GDDR7) supply, prompting an alleged 20% cut in GPU shipments and a prioritization of lower-VRAM SKUs; Nvidia states demand remains strong while working with suppliers. For investors, this implies near-term revenue and growth headwinds in the gaming GPU segment, potential SKU mix shifts, and execution risk around component sourcing, although sustained demand and product longevity may mitigate downside. Key quantified items: rumored RTX 5080 Super/5070 Ti Super/5070 Super specs were planned with higher GDDR7 capacities and increased TGPs, and supply reductions of roughly 20% were reported.

Analysis

Market structure: Memory-constrained delay of Nvidia (NVDA) consumer GPU launches shifts near-term value to memory suppliers (Micron MU, SK Hynix, Samsung) and semiconductor equipment (AMAT, LRCX). Expect Nvidia to prioritize lower-VRAM SKUs and cut unit shipments ~20% near-term, supporting DRAM/GDDR pricing and raising ASPs for memory vendors by a material amount (mid-teens % moves in spot/contract pricing over 3–9 months plausible). Gaming OEMs and downstream GPU-dependent MSI/ASUS may see inventory/discounting pressure.

Risk assessment: Tail risks include a prolonged memory shortage pushing NVDA to miss revenue guides (earnings shock within next 1–2 quarters) or regulatory action around channel prioritization; second-order risk is demand destruction if consumers delay upgrades for ~12–24 months. Immediate risk window is 0–90 days around quarterly commentary; medium-term is 6–18 months as RTX60 timing shifts. Hidden dependency: NVDA’s data-center AI revenue can offset consumer weakness, masking gaming weakness in headline results.

Trade implications: Favor long exposure to memory names (MU) and semiconductor-capex beneficiaries (AMAT/LRCX) 3–5% weights over 6–12 months; hedge NVDA directional exposure with 3–6 month puts or put spreads (0.5–1% notional) ahead of earnings. Consider pair trades: long MU vs short NVDA options skew if NVDA revises guidance; reduce direct consumer-GPU cyclicals and reweight into datacenter/AI leaders that are less memory-constrained.

Contrarian angles: Market may over-penalize NVDA given its dominant AI TAM — a >10% share-price decline could be a buying opportunity for 12–24 month holds because data-center cadence still accelerates annually. Conversely, memory vendors may already price in tightness; watch DRAM contract indices and Nvidia’s channel inventory data for mean-reversion within 3 months before adding size.

Key Decisions for Investors

• Establish a 3% portfolio position long MU (Micron) with a 6–12 month horizon to capture higher GDDR/DRAM ASPs; target +25–40% upside, trim if MU rallies >30% or DRAM contract prices fall >15% quarter-over-quarter.
• Reduce direct long NVDA exposure by 5–10% immediately; instead buy 3–6 month NVDA put spreads (OTM, size 0.5–1% notional) as earnings-season hedge—enter if shares rally into earnings or if implied vol for NVDA puts <40% (sell calls against decline if comfortable).
• Initiate a pair trade: long 2% AMAT (or LRCX) vs short 2% NVDA exposure via short-dated calls/written covered calls if carrying shares—expect equipment spending to benefit from memory tightness over 6–12 months; exit if AMAT underperforms NVDA by >10% in 90 days.
• Trim consumer-GPU-exposed suppliers (ASUS/MSI equivalent exposure) by 50% in the next 30 days and redeploy into AI/data-center names (NVDA core exposure only via covered positions) until memory-supply signals (DRAMeXchange weekly index, Nvidia channel inventory in next 2 earnings) normalize.